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WomenLeprosyhas an impact on the physical, social, andpsychological health of affectedpeople.Women indeveloping
countries seek health care late for any health-related issues. Leprosy, a disease known for its stigma, adds fur-
ther to these facts. Also, close contact betweenwomen and familymembers, especially children, increases the
chance of transmission to others and thereby increases the disease burden in the society. Hence, leprosy in
women is an important issue for the affected patient, their family members, and society as a whole.
© 2016 The Authors. Women's Dermatologic Society. Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Leprosy is a chronic granulomatous disease caused byMycobacte-
rium leprae. The disease is mainly classiﬁed as paucibacillary (PB) or
multibacillary (MB) leprosy, depending on the number of skin lesions
and nerve involvement. PB leprosy is a milder form of the disease,
characterized by few (i.e., up toﬁve) hypopigmented, pale and reddish,
hypo- or anesthetic skin lesions, whichmay at times be inﬁltrated. MB
leprosy is associated with multiple (i.e., more than ﬁve) skin lesions
that manifest as nodules, plaques, or diffuse skin inﬁltration (World
Health Organization, 2002). (See Figs. 1–5).
According to the Ridley and Jopling classiﬁcation (1966), leprosy
can bedivided intoﬁve groups: tuberculoid leprosy (TT), borderline tu-
berculoid leprosy (BT), mid-borderline leprosy (BB), borderline lepro-
matous leprosy (BL), and lepromatous leprosy (LL). Later, the leprosy
was reclassiﬁedwith the addition of pure neuritic leprosy and indeter-
minate leprosy. TT, BT, and indeterminate leprosy are considered PB
leprosy, and BB, BL and LL Hansen’s are classiﬁed as MB leposy. Pure
neuritic leprosy can fall on both spectrums depending on the number
of nerves involved and the bacillary load.
Indeterminate leprosy presents clinically as a vague hypopigmented
patch with some degree of loss in tactile and thermal sensation that
shows the presence of bacilli or perneural inﬁtartion in histopathology.
This is usually the ﬁrst sign of leprosy in 20% to 80% of patients
(Cardama, 1980). TT presents with well-deﬁned anesthetic plaque
with raised and clear-cut edges that slope inward. The surface looks
dry with hair loss and sweating, and the feeder nerve may thicken.Society. Elsevier Inc. This is an ope
, Leprosy andwomen, InterBTpresentswith an anesthetic patchwith regular-to-irregularmargins
that have a pseudopodial extension and satellite lesions in the vicinity
of patch. Several of the peripheral nerves are likely to be enlarged in an
asymmetrical pattern, with hair loss and sweating on the patches.
BB is an unstable form of the disease that can present with features
of both tuberculoid and lepromatous pole. The characteristic skin
lesions are annular lesions with a well-deﬁned, punched-out inner
edge and an ill-deﬁned outer-sloping edge that give the appearance
of Swiss cheese. Nerve damage is variable and depends on whether
the patient is upgrading from lepromatous pole or downgrading from
tuberculoid pole. In BL, there are slightly inﬁltrated, round-to-oval
macules of 2 to 3 cm in diameter that are distributed in an asymmetri-
cal pattern with areas of apparently normal skin between macules.
With the progression of disease papules, nodules and plaques may
develop with slope-like margins merging into the surrounding skin.
Peripheral nerve involvement is asymmetrical; however, the damage
is less compared with BT and TT.
LL presents asmacules, nodules, papules, and diffuse and inﬁltrated
forms. Macules in LL are smaller compared with BL, with indistinct
edges, shiny surfaces, and a symmetrical distribution. Diffuse LL has
shiny and thickened skin that is better felt with touch by pinching
the skin with ﬁngers. Earlobes are shiny and thickened. The nodular
form is the advanced stage of LL with nodules over the ear lobes,
face, trunk, joints, and extremities. Symptoms also include madarosis,
accentuation of skin folds, and bony deformities like nasal depression
giving rise to leonine facies. Nerve trunks are rarely involved; instead,
dermal twigs give rise to symmetrical loss of sensation initially over
the extensors of the extremities in a glove and stocking pattern
(Ridley and Jopling, 1966). Pure neuritic leprosy also presents with a
loss of sensation and the involvement of nerves that supply thosen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Fig. 1. Borderline tuberculoid leprosy with patch over face.
Fig. 3. Borderline tuberculoid leprosy with type 1 reaction.
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et al., 1976).
Although not life threatening, leprosy causes several stigmatizing
deformities and thereby has a great psychosocial impact on affected
people and their families. In developing countries like India, most
women are housewives who are neglected within the family, espe-
cially where health is concerned. Women are always the last to
seek healthcare, the most common being their ﬁnancial dependence
onmen. Hence, leprosy in women has a great impact on the health of
the affected patient and her family members, children, and commu-
nity as a whole.
In this review, we discuss the various aspects of leprosy inwomen,
including the prevalence; difference in clinical features; effects on
pregnancy, lactation, menstruation, ovarian function, fertility status,
and marital status; and response to treatment. However, not all
forms of leprosy have stigmata.Fig. 2. Borderline tuberculoid leprosy with patch over face and plaque over forehead in
type 1 reaction.
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Although the prevalence of leprosy has declined and the disease
was declared eliminated in 2005, endemic pockets remain in various
parts of the world. In 2014-2015, the prevalence rate was 0.68/
10,000; in 2013-2014, the proportions ofwomen and children affected
with leprosy were 36.81% and 9.04%, respectively. Traditionally, a
male-over-female preponderance has been reported in variousFig. 4. Nodular lepromatous leprosy with type 2 reaction along with clofazimine-in-
duced pigmentation.
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Fig. 5. Erythema nodosum leprosum lesions over the forearm.
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2002; Rao et al., 1996; Van Veen et al., 2006). Traditional beliefs, the
low status assigned towomen, andwomen’s limitedmobility, illiteracy,
and poor knowledge of leprosy have been suggested as important
sociocultural factors responsible for underreporting of cases of
women affected with leprosy.
In a study from Nepal, it was determined that most of the women
were illiterate, married at an early age, had a heavy workload, and
had poor knowledge and awareness of the clinical signs of leprosy
and its treatment. Affected women had to seek permission from
their mother-in-law or husband to leave the homestead and needed
escort andmoney for transportation and sometimes treatment. All of
these factors impeded women in reporting for an early diagnosis and
treatment (Varkevisser et al., 2009).
Gender-related difference
In various studies, it has been reported that women affected with
leprosy were of a younger age group compared with men (Arora
et al., 2008; Lockwood and Sinha, 1999). Hormonal imbalance related
to pregnancy and/or puerperium might be a possible cause of such
occurrence (Arora et al., 2008). With regard to MB prevalence,
women are in an advantageous position compared with men and
comprise a lower percentage of MB cases according to existing data
(Arora et al., 2008; Chisi et al., 2003; Hussein et al., 2010; Peters
and Eshiet, 2002; Varkevisser et al., 2009). Most published data
show that the incidence of chronic neuropathic ulcer is higher in
men compared with women, which may be due to underdiagnosis
inwomen (Kunst, 2000; Lema et al., 2012; Tiendrebeogo et al., 1999).
In a study from Southeast Nigeria, a higher proportion of women
had various deformities compared with men, and the duration gap
between appearance of signs and symptoms and diagnosis of leprosy
was almost double (Peters and Eshiet, 2002).
Because of the late presentation, there are more chances for
severe deformities in women. In countries like India, because a sig-
niﬁcant proportion of females are housewives, they engage in cooking
and other household activities and are vulnerable to repeated trauma,
ulceration, and other severe-grade deformities in leprosy.
Leprosy and pregnancy
Leprosy and pregnancy affect each other’s course. The clinical signs
and symptoms of leprosy are mostly due to the role of immunity and
depend on the immunological status of the host. Hormonal changes
during puberty or pregnancy lead to alteration in the host's immune
status. The ﬁrst appearance of leprosy, reactivation of the disease,
and relapse in “cured” patients are likely to occur particularly in thePlease cite this article as: Sarkar R, Pradhan S, Leprosy andwomen, Inter
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et al., 1981, 1982). Due to the variation in cell-mediated and humoral
immunity, lepra reactions are triggered by pregnancy (Duncan et al.,
1982). A type 1 reaction (reversal reaction) occurs during postpartum
phase, whereas a type 2 reaction (erythema nodosum leprosum)
peaks during late pregnancy. Both types of reaction can continue
long into lactation. Hence, affected women are vulnerable to sequelae
both due to leprosy and lepra reactions. Up to 20% of children born to
mothers with leprosy may develop leprosy by the time they reach
puberty. If marriage and childbearing occur at an early age in the
leprosy-affected daughters of mothers who have leprosy, they are
likely to experience the adverse effects of pregnancy on leprosy
(Duncan, 1993).
Effect of leprosy on fetus and children
Existing evidence shows that babies ofmotherswith leprosy have
a lower birth weight and smaller placentae, grow more slowly, and
experience more infections and higher infant mortality than those
of non-leprous mothers. Mothers affected with LL have more of
these ﬁndings compared to mothers with other variants of leprosy.
In a study by Duncan et al. (2007), it was found that children of
mothers affected with LL had more serious infections compared
with other groups of children. The pubertal skeletal growth spurt
and menarche in girls was delayed in children who were studied in
comparison with a healthy control group; they caught up by the
late teen years. These ﬁndings were mostly marked in children of
LL-affected mothers (Duncan et al., 2007). Impaired growth in utero
and infancy due to immunological factors have been suggested as a
possible cause for this observation.
Effect of leprosy on menstrual cycle and fertility status
Data are more scarce regarding the involvement of gonads in
female patients with leprosy. Existing studies show contradictory
ﬁndings. Mitsuda (1936); Mitsuda and Ogawa (1937) and Hardas
et al. (1972) suggested that leprosy does not have any effect on the
menstrual cycle or fertility. However, Sharma et al. (1981) found
that 10% of women affected with leprosy had primary infertility,
which was higher than the prevalence of infertility in the general
population in India (Jejeebhoy, 1995; Sharma et al., 1981). Similarly,
Fleger et al. (1963) found that 54% of female patients with leprosy
were sterile, and gross menstrual abnormalities were reported by
King and Marks (1958) in patients with leprosy. Bogush (1976) also
reported menstrual dysfunction in patients with leprosy, which
could be prevented by early institution of therapy.
In a study from India by Khanna et al. (2014), a signiﬁcantly larger
number of female patients with MB leprosy had irregular periods
postdating the onset of leprosy than patients with PB leprosy. The
study also found that gonadotropic hormone levels were elevated
in signiﬁcantly more patients with MB leprosy vis-à-vis patients
with PB leprosy, and that the mean levels of these hormones showed
an increasing trend from controls to patients with PB to patients with
MB leprosy.
Autoimmune disorders of the ovary often cause ovarian dysfunc-
tion, resulting in irregularity of the menstrual cycle and infertility
(Nandedkar and Wadia, 1998; Nelson et al., 2005). MB leprosy is
often associatedwith an autoimmune phenomenonwith various auto-
antibodies, such as anti-neutrophil cytoplasmic antibodies (ANCA),
A-ANCA, anti-mitochondrial antibodies, and anti-phospholipid anti-
bodies, found in the sera of patients (Freire et al., 1998; Garcia-De
La Torre, 1993; Guedes Barbosa et al., 1996; Park et al., 1992).
Hence, it has been suggested that autoantibodies directed against
components of the ovary might be a cause of ovarian failure.national Journal ofWomen'sDermatology (2016), http://dx.doi.org/
Table 1
World Health Organization multidrug therapy regimen for paucibacillary and multibacillary leprosy
Paucibacillary Leprosy Multibacillary Leprosy
Adult Once a month:
Day 1: rifampicin 600 mg + dapsone (100 mg) (supervised
dose)
Days 2–28: 1 tablet of dapsone (100 mg) once daily
Full course: 6 months
Once a month:
Day 1: rifampicin 600 mg + clofazimine 300 mg (100 mg X 3) + dapsone 100 mg
Once a day: Days 2–28
1 capsule of clofazimine (50 mg) and 1 tablet of dapsone (100 mg)
Full course: 12 months
Children 10–14 years:
Once a month:
Day 1: rifampicin 450 mg + dapsone 50 mg (supervised dose)
Days 2–28: 1 tablet of dapsone (50 mg)
Full course: 6 months
For children younger than 10 years of age, the dose must be
adjusted according to body weight.
10–14 years:
Once a month:
Day 1: rifampicin 450 mg + clofazimine 150 mg (50 mg X 3) +dapsone (50 mg)
Once a day:
Days 2–28: clofazimine every other day (50 mg) and 1 tablet of dapsone (50 mg)
Full course: 12 months
For children younger than 10 years of age, the dose must be adjusted according to body
weight.
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Various studies have proved that the level of stigma is quite high
in women affected by leprosy compared with men (Mankar et al.,
2011; Rafferty, 2005; Singh, 2012; Try, 2006; Vlassoff et al., 1996;
World Health Organization, 2002). The social and psychological com-
plications due to leprosy persist even after completion of treatment.
The effect of leprosy onmarital relationships is an important example
of a social complication. A qualitative study of the psychological
needs of men and women with leprosy in South Africa revealed
that one third of leprosy patients are abandoned by their spouses
(Scott, 2000). Another study fromNepal found that 48% of community
members thought that people affected by leprosy would encounter
marital problems (Adhikari et al., 2013).
A similar study fromNepal found that leprosy affected themarital
status of women in various ways. They face signiﬁcant problems
during treatment, which often lasts a full year. They do not have
intercourse at all due to the fear of contagion, are kept distant from
loved ones, and both spouses sleep in separate beds. Also, most of
the leprosy-affected women are abandoned or sexually abused by
their husbands even after treatment (van‘t Noordende et al., 2016).
Intolerance to multidrug therapy in women
Multidrug therapy (MDT) instituted by theWordHealthOrganiza-
tion in 1981 has been considered the gold standard treatment for
leprosy. The regimenhas undergone differentmodiﬁcations regarding
duration of therapy and doses. However, the currently recommended
duration is 6 months for PB and 12 months for MB (Table 1).
MDT includes rifampicin, dapsone, and clofazimine. Each drughas
its own side effect proﬁle, which varies by individual. However, there
is some evidence of gender-related differences in tolerance to MDT.
In one study, 23.6% of women were found to have MDT intolerance
to the PB regimen, leading to a greater change in the MDT regimen.
Anemia was the cause in 13.8% of cases (Dupink et al., 2013). Goulart
et al. (2002) found that reported incidence of hemolytic anemia
related to dapsone was higher in women compared with men.
Among the three drugs in MDT, clofazimine is well known for
causing visible, long-lasting changes in skin in the form of icthyosis
and hyperpigmentation. These changes are mostly cosmetically
disabling and unacceptable by many women, which further adds to
psychological stress (Hastings et al., 1988; Jamet et al., 1992; Singh
et al., 2011).
Nutritional status in women with leprosy
Recent studies regarding the nutritional status of leprosy patients
suggest that poor nutrition can indirectly lead to progression of the
clinical disease due to an indirect impact on cell-mediated immunity,Please cite this article as: Sarkar R, Pradhan S, Leprosy and women, Inter
10.1016/j.ijwd.2016.09.001but they do mention gender-related differences. However, women
are the most affected by poor nutrition in a family and hence have
more chances for progression of the disease. More studies are needed
to document this.Conclusions
This paper highlights the various aspects of leprosy in women in
developing countries over the last few decades (Le grand, 1997),
including prevalence, clinical features, complications, social aspects
and treatment-related issues. It highlights that screening, treating,
and rehabilitating women with leprosy is an important aspect of
leprosy programs, and counseling women and their spouses and
family members will go a long way in enabling female patients to
return to their normal lives.References
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